- Active ingredient
- palmitoylethanolamide ultra micronized
- Strength
- 300 mg
- Form
- tablet
- Manufacturer
- sakr pharmaceutical
- Route
- oral.solid
Uses
Ultra-micronized PEA (um-PEA) is used for the management of chronic and neuropathic pain, including sciatic pain, fibromyalgia-related pain, and neuroinflammatory conditions. Its enhanced particle size improves bioavailability.
Do not use if
Contraindicated in patients with known hypersensitivity to PEA or any excipients. Caution is advised during pregnancy and lactation due to limited safety data.
Side effects
Generally well tolerated. Mild gastrointestinal discomfort may occur. No significant organ toxicity or serious adverse effects have been reported in clinical studies.
Warnings
Not recommended as a substitute for prescribed analgesics in severe pain conditions without physician guidance. Keep out of reach of children.
How it works
Ultra-micronized PEA achieves greater mucosal absorption than standard PEA. It activates PPAR-α, modulates mast cell and microglial activity, and reduces pro-inflammatory cytokine release in neuronal and peripheral tissues, producing analgesic and neuroprotective effects.
Storage
Store at room temperature (below 25°C), in a dry place, protected from light and moisture.